thioctic acid has been researched along with 2,3,4-tri-o-acetylarabinopyranosyl isothiocyanate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ceruti, S; Di Cesare Mannelli, L; Francesconi, O; Ghelardini, C; Gualdani, R; la Marca, G; Magni, G; Merli, D; Moncelli, MR; Nativi, C; Richichi, B | 1 |
1 other study(ies) available for thioctic acid and 2,3,4-tri-o-acetylarabinopyranosyl isothiocyanate
Article | Year |
---|---|
Lipoic-based TRPA1/TRPV1 antagonist to treat orofacial pain.
Topics: Animals; Anti-Inflammatory Agents; Calcium Channels; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Facial Pain; Glial Fibrillary Acidic Protein; Humans; Isothiocyanates; Nerve Tissue Proteins; Patch-Clamp Techniques; Rats; Thioctic Acid; Transfection; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPV Cation Channels | 2015 |